drugset / Trial / NCT00876421
Study of ONO-8539 in Patients With Overactive Bladder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to investigate efficacy, safety and tolerability of ONO-8539 in patients with overactive bladder.
Timeline
- Start
- 2009-04
- Primary completion
- 2010-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ONO-8539 | Small molecule | — | — |
| Comparator | Tolterodine | Small molecule | 4 mg | — |